Results of ATHOS-3 Phase 3 Study of LJPC-501 Published in The New England Journal of Medicine

Results of ATHOS-3 Phase 3 Study of LJPC-501 Published in The New England Journal of Medicine


The article, entitled "Angiotensin II for the Treatment of Vasodilatory Shock," also will be published in the May 25, 2017 print issue of NEJM. "There is a major need for new treatment options for critically ill patients who do not adequately respond to available vasopressors," stated Rinaldo Bellomo, M.D., Professor of Intensive Care Medicine at University of Melbourne and Director of Intensive Care Research at Austin Health.



from Biotech News